Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Integra Artifical Skin receives CE Mark certification

March 27, 1998

Phase III trials of Microsponge-entrapped 5-FU begin in the U.S.

March 27, 1998

New retinoid-like compounds discovered at Allergan

March 25, 1998

Life Medical Sciences receives FDA approval to begin Repel-CV trials

March 25, 1998

FK-506: a topical agent for the treatment of moderate to severe atopic dermatitis

March 25, 1998

Positive trial results reported for AlloDerm

March 24, 1998

Potential new indication for zafirlukast in the treatment of urticaria

March 23, 1998

PSSO: an alternative to hydrocortisone for the treatment of erythema

March 23, 1998

Schering-Plough and Chugai sign marketing agreement for psoriasis drug

March 20, 1998

Botox effective in controlling focal hyperhidrosis

March 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...